Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tularemia.

Jill Ellis1, Petra C F Oyston, Michael Green

  • 1Defence Science and Technology Laboratory, CBS Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom.

Clinical Microbiology Reviews
|October 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors and Outcomes of Heart Failure Diagnosis in the Community When Compared to Acute Care Settings: Insights from Linked Administrative Health Databases.

Journal of cardiac failure·2026
Same author

Determining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process Evaluation.

JMIR research protocols·2026
Same author

Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Assessing Internist Competency in Point-of-Care Ultrasound Using the Entrustable Professional Activity Framework.

Journal of general internal medicine·2026
Same author

Relationship Between Navigation Success, Diagnostic Accuracy, and Ventilation Strategy: Retrospective Chart Review of 224 Consecutive Navigational Bronchoscopic Procedures Performed Under General Anesthesia.

Journal of clinical medicine·2026

Francisella tularensis causes tularemia, a severe disease. Diagnosis is challenging, and while a vaccine exists, improved options are needed, making antibiotics crucial for treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bioterrorism Preparedness

Background:

  • Francisella tularensis is the cause of tularemia, a significant zoonotic disease.
  • Ulceroglandular tularemia is common, transmitted by arthropod vectors, while pneumonic tularemia is rare but a bioterrorism concern.
  • F. tularensis is an intracellular pathogen, primarily residing in macrophages, with poorly understood virulence mechanisms.

Purpose of the Study:

  • To review the challenges in diagnosing and treating tularemia caused by Francisella tularensis.
  • To highlight the limitations in developing new vaccines due to difficulties in genetic manipulation and understanding virulence.
  • To emphasize the current reliance on aminoglycoside antibiotics for tularemia management.

Main Methods:

  • Literature review of diagnostic methods for tularemia.

Related Experiment Videos

  • Analysis of current vaccine strategies and their limitations.
  • Evaluation of antibiotic efficacy in tularemia treatment and prevention.
  • Main Results:

    • Current diagnostic methods like ELISA and PCR require further evaluation for pneumonic tularemia.
    • Development of defined F. tularensis mutants for vaccine research is hindered.
    • Aminoglycoside antibiotics remain the primary therapeutic and prophylactic agents for tularemia.

    Conclusions:

    • Accurate and rapid diagnosis of tularemia, especially the pneumonic form, remains a challenge.
    • Further research into F. tularensis virulence mechanisms is essential for improved vaccine development.
    • Effective management of tularemia currently relies heavily on aminoglycoside antibiotics in the absence of licensed vaccines.